T1	Outcomes 1555 1586	Protocol-defined cardiotoxicity
T2	Outcomes 1723 1784	Median cumulative doxorubicin dose at onset of cardiotoxicity
T3	Outcomes 1887 1908	overall response rate
T4	Outcomes 1947 1957	median TTP
T5	Outcomes 2019 2034	Median survival
T6	Outcomes 2123 2142	Clinical toxicities
T7	Outcomes 2306 2339	palmar-plantar erythrodysesthesia
